| Name | Renin receptor | ||
| UniProt ID | RENR_HUMAN | ||
| Gene Name | ATP6AP2 | ||
| Gene ID | 10159 | ||
| Synonyms |
ATP6AP2, APT6M8-9, ATP6IP2, ATP6M8-9, CDG2R, ELDF10, HT028, M8-9, MRXE, MRXSH, MSTP009, PRR, RENR, XMRE, XPDS
|
||
| Sequence |
MAVFVVLLALVAGVLGNEFSILKSPGSVVFRNGNWPIPGERIPDVAALSMGFSVKEDLSW
PGLAVGNLFHRPRATVMVMVKGVNKLALPPGSVISYPLENAVPFSLDSVANSIHSLFSEE TPVVLQLAPSEERVYMVGKANSVFEDLSVTLRQLRNRLFQENSVLSSLPLNSLSRNNEVD LLFLSELQVLHDISSLLSRHKHLAKDHSPDLYSLELAGLDEIGKRYGEDSEQFRDASKIL VDALQKFADDMYSLYGGNAVVELVTVKSFDTSLIRKTRTILEAKQAKNPASPYNLAYKYN FEYSVVFNMVLWIMIALALAVIITSYNIWNMDPGYDSIIYRMTNQKIRMD |
||
| Pathway Map | MAP LINK | ||
| T.C. Number | 8.A.80.1.1 | ||
| KEGG ID | hsa10159 | ||
| Pfam | PF01663; PF07850 | ||
| Pair Name | Toosendanin, Camptothecin | |||
| Phytochemical | Toosendanin | |||
| Drug | Camptothecin | |||
| Disease Info | [ICD-11: 2C77] | Cervical cancer | Investigative | |
| Regulate Info | Down-regulation | Renin receptor | Activity | |
| Result | These results suggest that toosendanin has the potential to be developed into an anti-cancer drug by blocking chemotherapy-induced protective autophagy. | |||
